These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 10079313)

  • 1. Establishment of a Non-Invasive Semi-Quantitative Bioluminescent Imaging Method for Monitoring of an Orthotopic Esophageal Cancer Mouse Model.
    Kuroda S; Kubota T; Aoyama K; Kikuchi S; Tazawa H; Nishizaki M; Kagawa S; Fujiwara T
    PLoS One; 2014; 9(12):e114562. PubMed ID: 25493557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer.
    Valtorta S; Nicolini G; Tripodi F; Meregalli C; Cavaletti G; Avezza F; Crippa L; Bertoli G; Sanvito F; Fusi P; Pagliarin R; Orsini F; Moresco RM; Coccetti P
    Invest New Drugs; 2014 Dec; 32(6):1123-33. PubMed ID: 25134489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of micro-CT and MRI in the assessment of longitudinal growth of liver metastases in a preclinical model of colon carcinoma.
    Pandit P; Johnston SM; Qi Y; Story J; Nelson R; Johnson GA
    Acad Radiol; 2013 Apr; 20(4):430-9. PubMed ID: 23498983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of tumor response to a vascular disrupting agent by hyperpolarized 13C magnetic resonance spectroscopy.
    Bohndiek SE; Kettunen MI; Hu DE; Witney TH; Kennedy BW; Gallagher FA; Brindle KM
    Mol Cancer Ther; 2010 Dec; 9(12):3278-88. PubMed ID: 21159611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An efficient synthetic strategy for obtaining 4-methoxy carbon isotope labeled combretastatin A-4 phosphate and other Z-combretastatins.
    Pettit GR; Minardi MD; Hogan F; Price PM
    J Nat Prod; 2010 Mar; 73(3):399-403. PubMed ID: 20028026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis.
    Hori K; Saito S
    Br J Cancer; 2003 Oct; 89(7):1334-44. PubMed ID: 14520469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical applications and advances of positron emission tomography with fluorine-18-fluorodeoxyglucose (18F-FDG) in the diagnosis of liver neoplasms.
    He YX; Guo QY
    Postgrad Med J; 2008 May; 84(991):246-51. PubMed ID: 18508981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases.
    Wiering B; Ruers TJ; Oyen WJ
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):607-13. PubMed ID: 15270664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of imaging photodynamic injury to tumours by high-resolution positron emission tomography.
    Moore JV; Waller ML; Zhao S; Dodd NJ; Acton PD; Jeavons AP; Hastings DL
    Eur J Nucl Med; 1998 Sep; 25(9):1248-54. PubMed ID: 9724373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET/CT in the evaluation of response to treatment of liver metastases from colorectal cancer with bevacizumab and irinotecan.
    Goshen E; Davidson T; Zwas ST; Aderka D
    Technol Cancer Res Treat; 2006 Feb; 5(1):37-43. PubMed ID: 16417400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.
    Findlay M; Young H; Cunningham D; Iveson A; Cronin B; Hickish T; Pratt B; Husband J; Flower M; Ott R
    J Clin Oncol; 1996 Mar; 14(3):700-8. PubMed ID: 8622014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 90Y microsphere treatment of unresectable liver metastases: changes in 18F-FDG uptake and tumour size on PET/CT.
    Bienert M; McCook B; Carr BI; Geller DA; Sheetz M; Tutor C; Amesur N; Avril N
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):778-87. PubMed ID: 15772860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography of murine liver metastases and the effects of treatment by combretastatin A-4.
    Zhao S; Moore JV; Waller ML; McGown AT; Hadfield JA; Pettit GR; Hastings DL
    Eur J Nucl Med; 1999 Mar; 26(3):231-8. PubMed ID: 10079313
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.